teloxantrone has been researched along with Neutropenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eisenhauer, E; Fine, S; Gelmon, K; Gregg, RW; Kaizer, L; Wielgosz, G | 1 |
| Eisenhauer, E; Erlichman, C; Kerr, IG; Moore, M; Whitfield, LR; Wong, B; Zee, B | 1 |
2 trial(s) available for teloxantrone and Neutropenia
| Article | Year |
|---|---|
A phase II trial of DuP 937 (Teloxantrone) in non-small cell lung cancer. A study of the NCIC Clinical Trials Group.
Topics: Aged; Anthraquinones; Antineoplastic Agents; Canada; Carcinoma, Non-Small-Cell Lung; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Pyrazoles | 1993 |
Phase I pharmacokinetic and pharmacodynamic study of a new anthrapyrazole, CI-937 (DUP937).
Topics: Adult; Aged; Agranulocytosis; Anthraquinones; Antineoplastic Agents; Drug Evaluation; Female; Humans; Leukocyte Count; Male; Middle Aged; Neoplasms; Neutropenia; Pyrazoles | 1991 |